Acetylsalicylic acid Completed Phase 4 Trials for Atrial Fibrillation / Acute Coronary Syndrome (ACS) Basic Science

Indications	Status	Purpose	Phase
DBCOND0000503 (Atrial Fibrillation) DBCOND0032938 (Acute Coronary Syndrome (ACS))	Completed	Basic Science	4

clinicaltrials.gov Identifier	Title	Drugs
NCT01812200	Antithrombotic Triple Therapy in Humans	Acetylsalicylic acid (DB00945) Dabigatran (DB14726) Phenprocoumon (DB00946) Rivaroxaban (DB06228) Ticagrelor (DB08816)